Pani Corp. Increases Stake in AI OKTO Corp. to 77.2%
Pani Corp. now owns 77.2% of AI OKTO Corp. shares, following recent market purchases, as revealed in a Schedule 13D amendment.
First Eagle Private Credit Fund updates ownership structure
First Eagle Private Credit Fund's recent filing reveals changes in ownership percentages, impacting the private credit fund landscape.
JPMorgan Public & Private Income Fund updates ownership filings
JPMorgan Public & Private Income Fund updates its ownership filings, indicating a change in executive leadership that may impact its strategic direction.
Canton Strategic Holdings grants stock options to board member
Canton Strategic Holdings, Inc. grants stock options to board member Sean Galvin, highlighting its commitment to leadership and strategy in finance services.
Nangalia Rishi acquires stock options from Canton Strategic Holdings
Nangalia Rishi reports acquisition of stock options from Canton Strategic Holdings, emphasizing equity compensation trends in finance services.
JPMorgan Public & Private Income Fund Reports Officer Change
Carmine Lekstutis is now Chief Loan Officer and Secretary at JPMorgan Public & Private Income Fund, marking a significant leadership change.
Venrock Healthcare Capital Partners XP Reports Stock Transactions
Venrock Healthcare Capital Partners XP, L.P. reported significant stock transactions involving Lycia Therapeutics, Inc., reflecting active investment strategies in biotech.
Beta Technologies CEO Clark Kyle Sells 30,000 Shares
Clark Kyle, CEO of Beta Technologies, sells 30,000 shares of Class A common stock, indicating ongoing financial adjustments and strategic planning.
Meringolo reports stock transactions for Hain Celestial Group
Kristy Meringolo reports stock transactions for Hain Celestial Group, reflecting her ongoing role and the company's commitment to transparency.
Canton Strategic Holdings grants stock options to board member
Canton Strategic Holdings, Inc. grants stock options to board member Pamela Carter, reflecting its commitment to leadership incentives in the finance services industry.
JPMorgan Public & Private Income Fund reports ownership change
JPMorgan Public & Private Income Fund files Form 3, indicating a change in ownership with Donald A. Gignac as a reporting director.
CEO Panagiotidis Increases Stake in AI OKTO Corp.
CEO Panagiotidis Petros Panagiotis boosts his stake in AI OKTO Corp. with recent stock purchases, signaling confidence in the company's future.
Canton Strategic Holdings grants stock options to board member
Canton Strategic Holdings, Inc. grants stock options to board member Jill Sommers, enhancing alignment with industry practices in finance services.
Goldenitsch Reports Share Transactions at Hain Celestial Group
Goldenitsch Wolfgang, President of Hain Celestial Group, reports share transactions involving restricted share units, reflecting executive compensation strategies.
Kahler Thomas Clay acquires stock options at Canton Strategic
Kahler Thomas Clay acquires stock options at Canton Strategic Holdings, signaling commitment and potential influence on investor confidence.
CFO Boyce Lee A. Reports Stock Transactions at Hain Celestial
Boyce Lee A., CFO of Hain Celestial Group, disclosed stock transactions including the vesting of restricted share units, reflecting trends in executive compensation.
Worley Dean L. acquires shares in Dillard's, Inc.
Worley Dean L. reports acquisition of shares in Dillard's, Inc., reflecting ongoing activity in the retail sector.
MUSGRAVE BRANT Acquires Shares of Dillard's, Inc.
MUSGRAVE BRANT reports acquisition of Dillard's shares, reflecting ongoing investment activity in the retail sector.
Epperly reports share transactions for Roivant Sciences Ltd.
Melissa B. Epperly disclosed share transactions for Roivant Sciences Ltd., acquiring 629 common shares under the company's director compensation plan.
Oren Ilan acquires additional shares of Roivant Sciences
Oren Ilan increases his stake in Roivant Sciences by acquiring 810 shares, totaling 124,490 shares held, signaling commitment to the pharmaceutical sector.